Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review.

J Ophthalmic Vis Res · 2014 · PMC4329707 · PMID 25709772

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP =0.07so close (0.05 < p ≤ 0.1)

Neovascular events showed a trend towards occurring later in eyes with perfused CRVO at baseline (log rank test, P =0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.